Aclaris Therapeutics
PublicAclaris Therapeutics is now publicly traded
The data on this page reflects Aclaris Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Oct 6, 2015
Last Round
Follow-on Offering
Oct 27, 2026
Total Funding Raised
$616.05M
Company Overview
Aclaris Therapeutics is a biopharmaceutical company that develops novel small and large molecule product candidates for immuno-inflammatory diseases and provides drug discovery and early development services through its subsidiary, Confluence Discovery Technologies.
Sector
Health Care
AI Layer
Non-AI
Keywords
Aclaris Therapeutics Comparables
Compare Aclaris Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reistone Biopharma | 84% | |
| Artax Biopharma | 76% | |
| Maxinovel Pharmaceuticals | 66% |
For institutional investors. Book with your work email.
Aclaris Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Oct 27, 2026 | ||||
| Private Placement | Nov 18, 2024 | ||||
| Follow-on Offering | Jun 14, 2021 | ||||
| Follow-on Offering | Jan 20, 2021 | ||||
| Debt | Mar 31, 2020 | ||||
Follow-on Offering | Nov 17, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aclaris Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | Follow-on Offering, IPO |
| RA Capital Management | Follow-on Offering, Private Placement, IPO |
| TCG Crossover | Follow-on Offering |
| Frazier Healthcare Partners | Series C, Series B, Series A |
| Guggenheim Securities | Follow-on Offering |
| Logos Capital | Private Placement |
| Forge Life Science Partners | Private Placement |
For institutional investors. Book with your work email.
Aclaris Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.